Table 2.
Univariate and multivariate logistic regression analysis for CIMT
| Parameter | HR; 95 CI% | P-value | HR; 95 CI% | P-value |
|---|---|---|---|---|
| Age | 1.09 (0.99, 1.13) | 0.040 | 1.02 (0.94–1.20) | 0.050 |
| Men | 1.24 (1.08–1.36) | 0.760 | ||
| Dialysis vintage | 1.42 (1.26–1.55) | 0.010 | 1.14 (0.99–1.29) | 0.306 |
| Smoking | 1.16 (1.06–1.32) | 0.050 | 1.06 (1.01–1.14) | 0.270 |
| Presence of type 2 DM | 6.32 (3.00–18.44) | 0.001 | 4.19 (1.44–8.60) | 0.380 |
| Positive cardiovascular history | 3.40 (1.17–9.56) | 0.029 | 2.36 (1.17–8.22) | 0.120 |
| Treatment with calcium-based phosphate binders | 2.43 (1.36–3.99) | 0.025 | 1.30 (1.19–2.41) | 0.150 |
| BMI | 0.98 (0.76–1.11) | 0.890 | ||
| Systolic BP | 1.08 (1.03–1.17) | 0.040 | 0.98 (0.95–1.01) | 0.478 |
| Diastolic BP | 0.98 (0.92–1.8) | 0.910 | ||
| LDL-cholesterol | 1.17 (1.00–1.29) | 0.192 | 1.05 (1.00–1.09) | 0.321 |
| HDL-cholesterol | 0.92 (0.86–1.01) | 0.340 | ||
| Triglycerides | 1.00 (0.98–1.02) | 0.870 | ||
| Hb | 1.17 (1.14–1.59) | 0.419 | ||
| Albumin | 0.64 (0.59–0.82) | 0.020 | 0.77 (0.62–0.88) | 0.326 |
| Calcium | 1.03 (0.98–3.01) | 0.898 | ||
| Phosphate (reference) T1 | 1.00 ( | 0.91 | ||
| T2 versus T1 | 1.08 ( | 0.73 | ||
| T3 versusT1 | 1.23 ( | 0.63 | ||
| Log serum intact PTH | 1.26 (1.10–1.62) | 0.044 | 1.13 (1.08–1.47) | 0.050 |
| 25-hydroxy vitamin D3 | 0.77 (0.72–0.91) | 0.660 | ||
| Sclerostin | 0.47 (0.33–0.66) | 0.006 | 0.61 (0.44–0.78) | 0.030 |
| Uric acid | 0.84 (0.69–1.09) | 0.510 | ||
| CRP | 1.22 (0.97–1.37) | 0.010 | 1.19 (0.99–1.28) | 0.019 |
| Alkaline phosphatase | 1.02 (0.99–1.22) | 0.472 |
DM, diabetes mellitus; BMI, body mass index; BP, blood pressure; Log iPTH, logarithm of serum intact parat hormone; CRP, C-reactive protein; T1, phosphate tertile 1 (<4.57 mg/dL); T2, phosphate tertile 2 (4.57, 5.26 mg/dL); T3, phosphate tertile 3 (>5.26 mg/dL).